Power Law company profile

Confo Therapeutics

Biotech & Life Sciences · Ghent, Belgium · Founded 2015 Colt

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$100–500M

Latest valuation · 2026

Unlock exact value

Revenue

$50–100M

Latest reported FY

Unlock exact value

Headcount

<100

Current team size

Unlock exact value

Investors

16 investors on Confo Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Seed 2 investors entered at this stage

Qbic Fund

Capricorn Partners

Series A 6 investors entered at this stage

Perceptive Advisors

The Institute for the Promotion of Innovation by Science and Technology in Flanders

BioGeneration Ventures

PMV

V-Bio Ventures

Wellington Partners

Series B+ 8 investors entered at this stage

Quest for Growth

University of Michigan

BioGenerator

Vrije Universiteit Brussel

Driehaus Capital Management

Flanders Institute for Biotechnology

FundPlus

Ackermans & van Haaren

Global footprint

Where Confo Therapeutics has talent and traffic

Web traffic by country

7.9K monthly visits
across markets

🇧🇪 Belgium59.5%

🇺🇸 United States30.4%

🇮🇳 India11.4%

Top 3 markets shown

See Confo Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo